AMY POINTON: Open Payments
NPI 1629361357 · GOSHEN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,706 in 86 payments from 14 companies in 2025. Trend: 2023 $1,742 · 2024 $2,187 · 2025 $1,706
Food & beverage: $1,706
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 26 | $478 |
| ABBVIE INC. | 28 | $464 |
| GENZYME CORPORATION | 7 | $193 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $183 |
| Regeneron Healthcare Solutions, Inc. | 4 | $86 |
| Boston Scientific Corporation | 1 | $84 |
| Intercept Pharmaceuticals, Inc. | 3 | $55 |
| Gilead Sciences, Inc. | 2 | $48 |
| Ardelyx, Inc. | 2 | $28 |
| QOL Medical, LLC | 1 | $20 |
Products named: TREMFYA, DUPIXENT, RINVOQ, ENTYVIO, MAVYRET, Axios, EOHILIA, Linzess.
Industry payments across IN — which companies pay providers there.
